Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines

Combined measles-mumps-rubella (MMR) vaccines produced by GSK (GSK-MMR) and Merck (Merck-MMR) have demonstrated effectiveness and an acceptable safety profile, as documented over decades of post-licensure use in various regions worldwide. In the United States, 2 doses of the MMR vaccine are recommen...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Md Ahsan, Povey, Michael, Casabona, Giacomo, Singh, Tina, Abu-Elyazeed, Remon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Vaccine Safety
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072070/
https://www.ncbi.nlm.nih.gov/pubmed/36988468
http://dx.doi.org/10.1080/21645515.2023.2188852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072070/
https://www.ncbi.nlm.nih.gov/pubmed/36988468
http://dx.doi.org/10.1080/21645515.2023.2188852

Ejemplares similares